Table 1 Patients' Characteristics.
Cancer groups | Patient No. | Gender | Age | TNM* | Staging |
|---|---|---|---|---|---|
LCNEC | 1 | F | 68 | T1N0M0 | IA |
| Â | 2 | M | 73 | T2N0M0 | IB |
| Â | 3 | M | 58 | T1N1M0 | IIA |
| Â | 4 | M | 70 | T2N0M0 | IB |
| Â | 5 | M | 76 | T2N2M0 | IIIA |
| Â | 6 | M | 69 | T3N3M0 | IIIB |
| Â | 7 | M | 64 | T2N1M0 | IIB |
| Â | 8 | M | 60 | T2N2M0 | IIIA |
| Â | 9 | F | 77 | T1N0M0 | IA |
| Â | 10 | M | 69 | T1N2M0 | IIIA |
SCLC | 1 | F | 62 | T2N0M0 | IB |
| Â | 2 | M | 77 | T2N1M0 | IIB |
| Â | 3 | M | 57 | T2N1M0 | IIB |
| Â | 4 | M | 76 | T1N1M0 | IIA |
| Â | 5 | M | 64 | T1N1M0 | IIA |
| Â | 6 | F | 70 | T1N1M0 | IIA |
| Â | 7 | M | 69 | T1N1M0 | IIA |
| Â | 8 | M | 77 | T2N0M0 | IB |
| Â | 9 | M | 73 | T1N0M0 | IA |
| Â | 10 | M | 73 | T2N1M0 | IIB |
LCC | 1 | M | 52 | T2N1M0 | IIB |
| Â | 2 | M | 71 | T1N0M0 | IA |
| Â | 3 | F | 57 | T1N0M0 | IA |
| Â | 4 | M | 51 | T4N2M0 | IIIB |
| Â | 5 | M | 72 | T1N1M0 | IIA |
| Â | 6 | M | 67 | T1N1M0 | IIA |
| Â | 7 | M | 67 | T2N0M0 | IB |
| Â | 8 | M | 58 | T1N0M0 | IA |
| Â | 9 | M | 67 | T2N0M0 | IB |
| Â | 10 | M | 66 | T1N0M0 | IA |